News

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
The Food and Drug Administration is suspending a quality control program for its food testing laboratories as a result of ...
The Iowa Department of Public Safety has signed an agreement with ICE to create a three-member task force deputized to enforce immigration laws.
Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...
The warning comes after a Recordati Pharmaceuticals reported an error in the labelling on some packs of Lercanidipine ...
Color additives have faced increased scrutiny since the FDA banned Red Dye No. 3, citing concerns over its links to cancer.
Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...
Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...
The Gila monster is a large, magnificent, and venomous desert-dwelling reptile found throughout the southwestern US and Mexico. A toxic bite from the Gila can cause searing pain, loss of consciousness ...
Roche gave an update this week about GENERATION HD2, testing the HTT-lowering drug tominersen in people with HD. The trial is ...
A deadly E. coli outbreak linked to romaine lettuce ripped through 15 states at the end of last year, but the Food and Drug ...